A new trading day began on Tuesday, with Spero Therapeutics Inc (NASDAQ: SPRO) stock price up 4.80% from the previous day of trading, before settling in for the closing price of $2.5. SPRO’s price has ranged from $0.51 to $3.22 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 17.67%. Meanwhile, its annual earnings per share averaged 63.78%. With a float of $40.31 million, this company’s outstanding shares have now reached $56.19 million.
Spero Therapeutics Inc (SPRO) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Spero Therapeutics Inc is 28.37%, while institutional ownership is 14.46%. The most recent insider transaction that took place on Aug 28 ’25, was worth 12,947. In this transaction Director of this company sold 6,572 shares at a rate of $1.97, taking the stock ownership to the 703,294 shares. Before that another transaction happened on Aug 28 ’25, when Company’s Chief Operating Officer sold 1,695 for $1.97, making the entire transaction worth $3,339. This insider now owns 739,744 shares in total.
Spero Therapeutics Inc (SPRO) Latest Financial update
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.32 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.22 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 63.78% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 15.36% during the next five years compared to 17.67% growth over the previous five years of trading.
Spero Therapeutics Inc (NASDAQ: SPRO) Trading Performance Indicators
Here are Spero Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.97. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.33.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.98, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -0.04 in one year’s time.
Technical Analysis of Spero Therapeutics Inc (SPRO)
The latest stats from [Spero Therapeutics Inc, SPRO] show that its last 5-days average volume of 0.57 million was inferior to 1.58 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 84.80%.
During the past 100 days, Spero Therapeutics Inc’s (SPRO) raw stochastic average was set at 57.75%, which indicates a significant decrease from 92.89% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.12 in the past 14 days, which was higher than the 0.11 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.17, while its 200-day Moving Average is $1.67. Now, the first resistance to watch is $2.68. This is followed by the second major resistance level at $2.75. The third major resistance level sits at $2.84. If the price goes on to break the first support level at $2.53, it is likely to go to the next support level at $2.44. The third support level lies at $2.37 if the price breaches the second support level.
Spero Therapeutics Inc (NASDAQ: SPRO) Key Stats
With a market capitalization of 147.44 million, the company has a total of 56,275K Shares Outstanding. Currently, annual sales are 47,980 K while annual income is -68,570 K. The company’s previous quarter sales were 14,190 K while its latest quarter income was -1,700 K.
